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Abstract
Background: Uterine fibroids are the commonest benign gynecological tumors. Laparoscopic myomectomy is
becoming increasingly popular as one of the surgical treatment options for symptomatic cases. Large tissues such
as leiomyomas or even the uterus need to be morcellated in order to be retrieved from the abdominal cavity.
Some of the morcellated fragments or small fibroids may be accidentally left in the abdominal cavity during the
retrieval process. These may subsequently become implanted in the abdominal cavity, develop blood supply from
the surrounding structures, and grow to form parasitic myomas with varied clinical presentation, depending on the
location and size.
Case presentation: A 47-year-old African woman presented to our hospital 6 years after laparoscopic myomectomy
with a lower abdominal mass. Her work-up revealed an anterior abdominal wall mass consistent with uterine
leiomyoma. She was scheduled for excision of the mass, which was subsequently histologically confirmed to be a
uterine fibroid.
Conclusions: Parasitic leiomyomas are a rare late complication of power morcellation following laparoscopic
myomectomy or hysterectomy. Most patients present with an abdominal/pelvic mass and may need surgical
excision to relieve the symptoms. Care should be taken during power morcellation to prevent excessive
fragmentation of the tissues, some of which may become implanted and persist to form parasitic myomas.
Moreover, effort should be made to retrieve all myoma fragments by carefully checking the abdominal cavity.
Whenever possible, the morcellation should be done in a containment bag.
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Background
Uterine fibroids are the most common benign gynecological tumors of the female genital tract. Despite their
relatively high prevalence, clinically apparent in up to 40%
of women over 40 years of age, the majority of the patients
with uterine fibroids are asymptomatic [1, 2]. Various
treatment modalities have been employed for symptomatic patients, ranging from medical to surgical interventions. Surgical management may be performed
through laparotomy or minimally invasive surgery,
among others [1, 3].
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The increasing availability of power morcellators has
made it possible for large leiomyomas to be removed
laparoscopically with the benefit of decreased blood loss,
shorter hospital stay, and faster recovery time [2, 4, 5].
Other options for tissue retrieval, such as through a colpotomy incision or through a minilaparotomy, are becoming less popular [2]. The fragmentation of the
fibroids using the morcellator may lead to peritoneal
seeding, which, if not detected at the time of the operation, may grow to form parasitic leiomyomas [1, 2].
This is a rare late complication of laparoscopic myomectomy [6]. We present a case of a 47-year-old woman
who presented with a left port site leiomyoma recurrence after laparoscopic myomectomy with power morcellation, and we review the current literature on
myoma recurrence after laparoscopic myomectomy.
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Case presentation
A 47-year-old, para 3 + 0, of African descent presented
with a lower abdominal mass that had been progressively increasing over a 3-year period. The mass was on
her left lower abdomen and was not painful. Six years
earlier, she had undergone laparoscopic myomectomy
with power morcellation for myoma retrieval.
She also reported persistent menorrhagia and dysmenorrhea since the previous surgery, for which she was
mainly receiving medical therapies. These included tranexamic acid and mefenamic acid with the onset of menses, which provided good symptom relief. She reported
no symptoms of anemia, such as easy fatigability, palpitations, or dyspnea, and had not used any hematinics
prior to the current presentation. Her Papanicolaou
smears for cervical cancer screening were up-to-date
with normal cytology.
All her three deliveries were through cesarean section,
two before and one after the initial surgery. She had no
urinary symptoms such as frequency of micturition, dysuria, or incomplete voiding. In addition, she had no
bowel symptoms such as constipation.
The examination revealed an anterior abdominal wall
mass in the left iliac fossa. The mass was firm, mobile,
and nontender overlying the previous left laparoscopy
port site (Fig. 1). This was the site used for morcellation
during the previous laparoscopic myomectomy. In
addition, she had a bulky 16-week fibroid uterus.
Her preoperative work-up included a pelvic ultrasound
examination, which revealed multiple intramural fibroids
with a superficial left hypoechoic mass in the left iliac
fossa region measuring 4 cm by 3 cm. Abdominopelvic
magnetic resonance imaging (MRI) revealed an anterior
abdominal mass measuring 7.2 cm by 5.1 cm by 3.4 cm
on the anterior abdominal wall in the left iliac fossa
(Fig. 2). A full hemogram revealed a hemoglobin level of

Fig. 1 Lower anterior abdominal wall mass at the previous left
laparoscopic myomectomy port site
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11.8 g/dl, white blood cell count of 4.2 × 109/L, and
platelet count of 261,000 × 109/L.
Management options were discussed, and the patient
opted to have a total abdominal hysterectomy and excision of the abdominal mass. The hysterectomy was done
through the previous cesarean section scar site. A separate 5-cm incision was made over the left iliac fossa via
the previous 12-mm port site scar, and dissection was
done to retrieve a 7.5-cm by 5.5-cm by 3.5-cm parasitic
myoma (Figs. 3 and 4). The parasitic myoma was inaccessible through the previous cesarean section scar,
necessitating a separate incision. In addition, the parasitic
myoma was attached to the subcutaneous tissue with no
visceral or major vascular attachments. The histology of
the mass showed interlacing bundles of benign smooth
muscle fibers consistent with a leiomyoma. The patient’s
postoperative recovery was uneventful, and her review
6 months following the surgery was unremarkable.

Discussion
Laparoscopic myomectomy and hysterectomy are increasingly becoming more available. To aid in tissue removal, large tissues such as the uterus and leiomyomas
are often fragmented with the use of power morcellators.
Some of the resultant small fragments may inadvertently
remain in the abdominal cavity and become implanted
with development of blood supply, resulting in subsequent growth [7–9]. These parasitic leiomyomas form a
rare late sequela of laparoscopic myomectomy [10, 11]
with an incidence of 0.2–1.25% and a median diagnosis
interval of 48 months [1, 2, 5]. Our patient first noted
the abdominal mass at about 36 months after her laparoscopic myomectomy with eventual confirmation at
about 72 months. Despite better patient outcomes following minimally invasive surgery, caution should be applied to prevent the spread of occult sarcomas, which
would significantly lower patient survival [12–14].
The clinical presentation is quite nonspecific and depends on the site of recurrence. The common sites include the pelvic cavity/wall, small intestines, rectum,
cecum, vaginal/cervical stump, and laparoscopic port
site [5, 7, 10]. Most patients will be asymptomatic with
an incidental finding of the parasitic myoma during other
investigations or procedures, especially if small [2, 8].
However, when symptomatic, the most common symptoms include abdominal/pelvic pain, abdominal mass or
pressure, abdominal distention, and vaginal bleeding
[2, 10]. Our patient presented with a progressively increasing abdominal mass. The absence of pain and
pressure symptoms on the bladder or bowel may have
contributed to a delay in her presentation.
Given the nonspecific presentation, there is no specific
investigation that is ideal in the diagnosis of parasitic
myomas. The definitive diagnosis requires confirmation
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Fig. 2 Hyperintense T2-weighted magnetic resonance imaging studies showing the parasitic left iliac fossa anterior abdominal wall myoma with
cystic degeneration

at histology, given the tendency to find the lesions distant from the uterus. However, histology of a benign
smooth muscle tumor distant from the uterus in a patient with a history of laparoscopic myomectomy with
morcellation should increase the suspicion of a parasitic
leiomyoma [10]. This is also important in order to differentiate this benign condition from other malignant abdominal conditions.
The initial investigation, just as in cases of a patient
presenting with a pelvic mass, should therefore include a
pelvic ultrasound. MRI may further help in distinguishing benign leiomyomas from other solid pelvic and abdominal tumors [10]. The nondegenerated myomas are
typically hypointense on T2-weighted images and isointense on T1-weighted images. The difficulty in differentiating the benign leiomyoma from the malignant
leiomyosarcoma emphasizes the need for a thorough
clinical history and histological diagnosis. Our patient
had a pelvic scan and an abdominopelvic MRI.

Fig. 3 Parasitic myoma at the previous 12-mm left laparoscopy port
site before excision

Measurement of tumor markers such as CA 125,
α-fetoprotein, or CA19-9 may be done, though they may
be falsely elevated with occasional ascites [10]. Our patient had no clinical or radiological ascites, and given
her previous history of laparoscopic myomectomy, we
did not consider measuring the tumor markers, because
the mass was unlikely to be malignant. However, in cases
of suspected malignancy such as leiomyosarcoma, tumor
markers may be useful in monitoring therapy and
follow-up, especially if initially elevated [15].
Treatment involves excision of the parasitic myoma.
This would be achieved through laparoscopy with good
outcomes or through laparotomy, especially in cases of
large myomas or suspected malignancy. In our patient,
excision was performed through a laparotomy. Whenever
possible, a multidisciplinary approach should be used,
especially when the parasitic myoma is near other organs
[10]. This was not necessary in our patient, however,
because the myoma was on the anterior abdominal wall.

Fig. 4 Parasitic myoma after excision
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To reduce the risk of developing parasitic leiomyomas
following power morcellation, various alternatives have
been suggested [1, 9]. The morcellation can be performed in a containment bag. This reduces spread of the
morcellated fragments. However, when malignancy is
suspected, morcellation should be avoided. Large specimens can be retrieved from the abdominal cavity by
bisecting or by cutting in small portions that can then
be removed though colpotomy or minilaparotomy. In
addition, it is essential to carefully check the abdominal
cavity after morcellation to avoid leaving myoma fragments [2, 4, 8], though this may still be insufficient to
remove all tissue fragments [9].

Conclusions
Parasitic leiomyomas are a rare late complication of
power morcellation following laparoscopic myomectomy
or hysterectomy. Most patients present with an abdominal/pelvic mass and may need surgical excision to relieve the symptoms. Care should be taken during power
morcellation to prevent excessive fragmentation of the
tissues, some of which may become implanted and persist to form parasitic myomas. Moreover, effort should
be made to retrieve all myoma fragments by carefully
checking the abdominal cavity. Whenever possible, the
morcellation should be done in a containment bag.
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